In the CAPItello-291 trial of capivasertib plus fulvestrant, 73% of patients had already received a CDK4/6 inhibitor. As ...

Medicaid programs made more than $200 million in improper payments to healthcare providers between 2021 and 2022 for people ...

The FDA approved a pill version of the GLP-1 receptor agonist semaglutide (Wegovy), making it the first oral GLP-1 agent ...

The public's views of measles, mumps, and rubella (MMR) vaccine safety and effectiveness have dropped, as has willingness to ...

The problem arises when systems blur distinctions in ways that confuse patients and strain teams. The real fault line in ...

Concurrently, low state immunization levels pose a significant and immediate risk, particularly for measles, which is ...

Science Signaling retracted a 2017 paper that linked a specific amyloid form (amyloid-beta 56) to tau pathology after an ...

At the San Antonio Breast Cancer Symposium, investigators reported findings from a retrospective study exploring whether ...

The FDA has expanded the indication of ferric maltol (Accrufer) capsules for the treatment of iron deficiency to include ...

FcRn blockers are approved for other indications: efgartigimod for adults with generalized myasthenia gravis and in ...